Clinical effect of pranoprofen eye drops for mild and moderate dry eye–a multicenter, randomized, controlled clinical trial

Sodium hyaluronate
DOI: 10.3760/cma.j.issn.2095-0160.2015.09.015 Publication Date: 2015-09-10
ABSTRACT
Background Nonsteroidal anti-inflammatory drugs are widely used in the treatment of dry eye, but related multicenter clinical study is lack. Objective This aimed to evaluate clinic efficacy pranoprofen eye drops for eye. Methods This protocol followed Declaration Helsinki, and oral informed consent was obtained from each patient prior entering cohort. A randomized, open, parallel, controlled, multi-center trial conducted. Total 1 023 patients with were enrolled based on same diagnosis criteria 58 institutes China July 2011 2012. The randomized into group control group. combination 0. 1% pranoprofe (4 times per day) sodium hyaluronate group, only way primary evaluated indexes included corneal fluorescence staining scores break-up time tear film (BUT), secondary outcome measurements symptom palpebral conjunctiva congestion papilla as well Shirmer Ⅰ test (SⅠt). best corrected visual acuity (BCVA) adverse response compared between two groups. Results The demography matched groups (both at P>0. 05). 76±0. 66 35±0. 54 14 days 28 after which lower than 1. 41±0. before (t=24. 439, 37. 236, both P=0. 000); those 84±0. 65 45±0. 60 treatment, significant reduce comparison (1. 62) (t=19. 702, 29. 517, 000). score significantly (t=8. 384, 004). BUT delayed (4. 88±2. 40)seconds (6. 03±3. 25) seconds versus (3. 47±2. 10) (t=-13. 358, -17. 734, 000), so ([4. 62±2. 21] [5. 42±2. 70] [3. 50±1. 52] [t=-13. 984, t=-17. 879, 000]). longer (t=10. 483, 001). In addition, symptom, post-treated (all P 05). Conclusions Pranoprofen has a better effect eye. can relieve symptoms signs very well, especially mild moderate patients. Key words: Dry eye; Non-steroidal drugs; Pranoprofen; Inflammation
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES ()
CITATIONS ()
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....